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In the present study the physicochemical stability of sertraline with lactose was evaluated
in drug-excipient binary mixtures. Different physicochemical methods such as differential
scanning calorimetry (DSC), Fourier-transform infrared spectroscopy, and mass spec-
trometry were applied to confirm the incompatibility. The final aim of this study was to
evaluate the kinetic parameters using a fast and sensitive DSC method. Solid-state kinetic
parameters were derived from nonisothermally stressed physical mixtures using different
thermal models such as Friedman, FlynneWalleOzawa, and KissingereAkahiraeSunose.
Overall, the instability of sertraline with lactose was successfully evaluated. Further
confirmation was made by tracking the Maillard reaction product of sertraline and lactose
by mass spectrometry. DSC scans provided important information about the stability of
sertraline in solid-state condition and also revealed the related thermokinetic parameters
in order to understand the nature of the chemical instability.
Copyright © 2016, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
LLC. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Drug product stability can be influenced by formulation com-
ponents in different aspects such as organoleptic or dissolu-
tion changes and chemical degradations. These changes may
lead to loss of potency and production of unsafe degradationent of Pharmaceutical an
ed.ac.ir, Monajjemzadeh
inistration, Taiwan. Publis
/licenses/by-nc-nd/4.0/).
F, et al., Physicochemica
Analysis (2016), http://dx.products. Some of the main factors affecting formulation
stability include existence of reactive groups in drug and
excipient structures, moisture content, drug/excipient ratio,
light, relative humidity, temperature, and packaging [1,2].
Thermal analysis includes a group of techniques in which
the properties of thematerials can be studied while heating ord Food Control, Tabriz University of Medical Sciences, Daneshgah
f@yahoo.com (F. Monajjemzadeh).
hed by Elsevier Taiwan LLC. This is an open access article under the CC
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evaluation of possible interactions in pharmaceutical formu-
lation since 1970 [3,4]. Thermal methods have been applied in
different pharmaceutical fields such as selection of a suitable
salt form, evaluating the phase-diagrams, active pharmaceu-
tical ingredient -excipient interactions, and to predict the
physical changes on processing or during drug storage [5,6].
Calorimetry is a fundamental tool used in pharmaceutical
industries which measures heat effects related to phase
transition and chemical reaction as a function of temperature.
Differential scanning calorimetry (DSC) was developed by E.S.
Watson and M.J. O'Neill in 1962 and introduced commercially
in 1963. This method is the only method for direct measure-
ment of the enthalpy related to the studied processes [7,8].
DSC provides important data about drug-excipient in-
teractions which can cause significant changes in the chemi-
cal properties, stability, solubility, absorption, and safety of
drug molecules [4,9,10]. Multiple scan method at different
heating rates using isoconversional calculationprocedures is a
fast and precise method, in order to calculate solid-stateFigure 1 e Selected differential scanning calorimetry (DSC) curve
with 1:1 mass ratio (b¼ 10) and (B) sertraline lactose 1:1 w/w bina
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binary mixtures, Journal of Food and Drug Analysis (2016), http://dx.kinetic parameters. Friedman (FR), KissingereAkahirae-
Sunose (KAS) and FlynneWalleOzawa (FWO) methods have
been commonly used to study the kinetic parameters in solid
state chemical interactions [11,12].
Fourier transform infrared spectroscopy (FTIR) is another
reliable and accurate technique which is used in drug stability
evaluations based on the formation of new absorption peaks
or disappearance of already existing infrared absorptions [13].
Sertraline [(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-
tetrahydronaphthalen-1-amine] is an antidepressant and acts
by selective serotonin reuptake inhibition. This drug is pre-
scribed for major depression, panic, obsessiveecompulsive
disorders, social anxiety, and premenstrual dysphoric disor-
ders [14].
Since sertraline is widely formulated and used in depres-
sion therapies and it has been previously shown that Maillard
reaction is the most probable incompatibility reaction of
amine-containing drugs with reducing carbohydrates, it is
expected that an incompatibility interaction occurs between
sertraline and lactose as a reducing carbohydrate. However, tos of (A) sertraline, lactose, and sertralineelactose mixture
rymixture at different heating rates (b¼ 2.5, b¼ 10, b¼ 15).
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on the possible instability of sertraline with lactose, up to the
date of this investigation [15].
The aim of this research was to evaluate the possible drug
instability using different analytical methods (DSC, infrared
spectroscopy, andmass spectrometry) and also to obtain basic
information about the drug molecule stability in solid state
using DSC based fast and reliable thermokinetic parameters.2. Material and methods
2.1. Materials
Sertraline was obtained from Novin Kavosh Mamatir Co.
(Tehran, Iran) and anhydrous lactose was provided from DMV
Chemical Co. (Veghal, TheNetherlands). NaOHwas purchased
from Merck (Darmstadt, Germany). All other chemicals were
of pure grades and obtained from Merck.
2.2. DSC
A Shimadzu differential scanning calorimeter (Kyoto, Japan)
was used for thermal analysis of pure drug, excipient, and
their binary mixtures. Binary mixture (10 g) consisted of equal
masses of sertraline and lactose was weighed into an amber
glass flask; uniform blending was achieved by the tumbling
method. Then, 5 mg of each sample was weighed in the DSC
aluminum pan and scanned in the temperature range of
25e300C at various heating rates (2.5C/min, 10C/min, and
15C/min). Enthalpy calculations were performed using TA-60
software (version 1.51) (shimadzu, Japan).
2.3. FTIR
Sertraline and lactose were blended in 1:1 mass ratios, mixed
with 20% (v/w) water, and stored in closed vials at 70C for 3
weeks [16].Figure 2 e Fourier transform infrared (FTIR) spectra of (A) lactose,
immediately after mixing, and (D) binary mixture with 20% add
Please cite this article in press as: Ghaderi F, et al., Physicochemica
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also after storage using the potassium bromide disc prepara-
tion method (MB-100 series, Bomem, Quebec, Canada). The
spectrum was an average of 10 sequential scans on the same
sample and the resolution was kept constant at 4 cm1. FTIR
data was processed by GRAMS/32 version 3.04 (Galactic In-
dustries Corporation, Salem, NH, USA).2.4. Mass spectrometry
Mass analysis was performed on the Waters 2695 Quadrupole
mass system (Milford, MA, USA), at electron-spray ionization
mode (positive ionization). These settings were applied to the
mass system. The capillary voltage, cone voltage, extractor
voltage, RF lens voltage, source temperature, desolvation
temperature, desolvation gas flow, and cone gas flowwere set
at 3.5 V, 30 V, 3 V, 0.10 V, 80C, 350C, 500 L/h, and 50 L/h,
respectively.3. Result and discussion
3.1. DSC
DSC can successfully assess the drug-excipient compatibility,
as well as provide important data, such as drug purity, drug
stability, polymorphic forms, and their stabilities [17e19].
Selected DSC curves of sertraline, lactose, and ser-
tralineelactose mixture are shown in Figure 1. Thermal
behavior of pure drug and pure excipients, as well as the bi-
nary mixture, were analyzed in the DSC curves.
According to Figure1A, sertraline presented its melting
point at 248.9C, and revealed a small endothermic peak at
208.8C which related to the polymorphic form V of sertraline
[20].
The endothermic peak of pure anhydrous lactose appeared
at 239.1C (b¼ 10).(B) sertraline, (C) sertralineelactose 1:1 w/w binary mixture
ed water after 3 weeks incubation at 70C.
l analysis and nonisothermal kinetic study of sertralineelactose
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Figure 3 e Positive ion mode electrospray mass spectrum of sertralineelactose mixture after 5 hours storage at 90ºC.
j o u r n a l o f f o o d and d r u g an a l y s i s x x x ( 2 0 1 6 ) 1e84In sertraline lactose mixture, the endothermic change
which was related to the polymorphism was seen as a very
weak peak at about 190C. The small shift in the mixture
compared to the pure sample can be due to the presence of
another component in the mixture. Disappearance of ser-
traline melting peak and also appearance of a new endo-
thermic peak at 215.7C in the sertralineelactose mixture can
only indicate the interaction between the binary mixtures
components under nonisothermal DSC conditions
(Figure 1A).
According to Figure 1B, while increasing heating rates, DSC
curves were shifted to higher temperatures. It has beenFigure 4 e Proposed structures for Mailla
Please cite this article in press as: Ghaderi F, et al., Physicochemica
binary mixtures, Journal of Food and Drug Analysis (2016), http://dx.previously shown that the heating rate changes have
remarkable effects on the temperature range and the shape of
curves [21].
3.2. FTIR
The application of FTIR is based on the integral analysis of the
spectra. Study of any changes in the position or intensity of
the peaks, as well as appearance or disappearance of the ab-
sorption band(s) can indicate drug instability and provide
valuable information about the mechanism of the possible
interaction [22,23].rd reaction of sertraline with lactose.
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mixture immediately after mixing and 3 weeks after incuba-
tion in an oven (t¼ 70C) are shown in Figure 2.
The main IR absorptions of sertraline were seen at 3420
cm1 for NeH stretching, 2472 cm1 for NH2
þ vibration (due to
hydrochloride salt), 1647 cm1 and 1463 cm1 for CeC ring
vibrations, 1591 cm1 for NeH bending stretching, 2934 cm1
and 1399 cm1 for -CH3 vibrations, 1128 cm
1 for CeN
stretching, 821 cm1, 776 cm1, and 738 cm1 for CeCl [24].
The main IR signals of lactose were: approximately
3459 cm1, 3292 cm1, and 2811 cm1 (OH), and 2879 cm1
(CH2, CH3).
Lactose-sertraline mixture's spectrum corresponded to the
sum of each component's peaks. In the lactose-sertraline
mixture after 3 weeks incubation at 70C, new peaks with
different shapes were generated at 1649 cm1, which can be
related to the formation of a C¼N covalent band. Also, ser-
traline's amine peak (1591 cm1) was eliminated, which can be
indicative of the contribution of the amine functional group in
the interaction andmay be indicative to the Maillard reaction.3.3. Mass spectrometry
Aphysicalmixture of sertraline and lactose (1:1) was dissolved
in a solution of NaOH 0.25M and stored at 90C. After 5 hours,
suitable dilutions were made using methanol. The diluted
sample (10 mg/mL based on sertraline) was injected directly to
the mass system. Mass spectra are presented in Figure 3.
The full-scan positive ion electrospray product ion mass
spectra showed that the molecular ion of sertraline and the
daughter ion were the protonated molecules [MþH]þ of m/z
307.0 and 277.3, respectively [24]. Proposed structures for
Maillard type interaction products are presented in Figure 4.
The m/z value at 649.8 is related to [MþH]þ of the condensa-
tion product in Figure 4.
Mass spectrometry is an appropriate and sensitive tech-
nique that is applied to a wide range of pharmaceutical
compounds [25,26]. Several studies have detected the lactose
and various drug substances condensation products such as
hydrochlorothiazide, fluoxetine, and metoclopramide by
mass spectrometry [27e29]. We have previously studied the
compatibility of acyclovir, baclofen, and gabapentin with
lactose in physical mixtures and commercial tablets using
mass spectrometry [30e33]. According to mass results in this
study, the condensation product of sertralinewith lactosewas
successfully detected.3.4. Kinetic study
Thermokinetic parameters were calculated based on the mul-
tiple scan method at different heating rates as a fast method
for assessment of pharmaceutical products stability [21].Figure 5 e (A) KissingereAkahiraeSunose diagram for sertraline
and 15C/min) and various conversion degrees (a¼ 0.1e0.9). (B)
lactose at different heating rates (2.5C/min, 10C/min, and 15C
Friedman's plot for sertralineelactose at different heating rates
0.1e0.9).
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study the kinetic parameters in solid state interactions [11,12].
Eq. (1) corresponds to the KAS method:
ln

b
T2

¼ ln A$ R
E· g að Þ 
E
R· T
(1)
in which, T is the temperature, b is the heating rate (C/min), g
(a) is the reaction model, E is the activation energy, A is the
pre-exponential factor, and R is the gas constant.
The values of (lnb/T2) were plotted versus 1/T and are
shown in Figure 5A. Activation energy (E) was obtained from
the slope of the regression straight lines and listed in Table 1.
FWO's isoconversional method is based on Eq. (2):
lnb ¼ lnðA·EÞ
R·gðaÞ  5:331 1:052·
E
R·T
(2)
The plot of lnb versus (1/T) is shown in Figure 5B. According
to the diagram, the correlation is linear. Activation energy (E)
was obtained from the slopes of the straight lines and is listed
in Table 1.
The isoconversional FR method is based on Eq. (3):
ln

b
da
dT

¼ ln½A·gðaÞ 

E
R·T

(3)
The plot of lnðb· dadTÞ versus (1/T) is linear. The values of
activation energy (E) were obtained from the slopes of the
straight lines in Figure 5C for sertralineelactose and presented
in Table 1.
In Eq. (3), a is the extent of conversion.
As presented in Table 1, the values obtained by three
methods are in a good agreement. Small standard deviation
values showed the acceptable reproducibility of results. The
reaction kinetics present important information about the
reaction features and are used to compare different reaction
conditions.
In all mentioned thermal models, it is assumed that re-
action progresses according to the first order reaction equa-
tion [34]. Based on this assumption, the values of k, t1/2, t90%,
and r2 were calculated for different heating rates. The higher
the heating rate, the lower the half-life values. Themaximum
and minimum t1/2 values that were related to the 2.5C/min
and 15C/min heating rates were calculated as about 75 sec-
onds and 20 seconds, respectively. The corresponding t90%
was assigned as about 11 seconds and 3 seconds,
respectively.
Although DSC presents a fast and versatile kinetic evalu-
ation, the resulting data should be interpreted carefully. For
example, in some cases the melting endotherm of the drug
and excipient may overlay and/or the drug may be dissolved
in themelted excipient whichmelts below the drug substance
melting point. In these cases, DSC data cannot be used to
evaluate the instability of the drug substance [34,35].and lactose at different heating rates (2.5C/min, 10C/min,
FlynneWalleOzawa (FWO) diagram for sertraline and
/min) and various conversion degrees (a¼ 0.1e0.9). (C)
(2.5, 10, and 15) and various conversion degrees (a ¼
l analysis and nonisothermal kinetic study of sertralineelactose
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Compatibility studies, kinetic evaluation, and tracking of the
reaction product were performed using different analytical
methods including DSC, FTIR, and mass spectrometry. Ac-
cording to DSC and FTIR results, presence of incompatibility
between sertraline and lactose was revealed.
Activation energy of the proposed reaction was estimated
using DSC data at different heating rates andMaillard reaction
product was successfully tracked using mass spectrometry.
According to the results, DSCprovides fast andsensitivekinetic
data, in comparison with the high performance liquid chro-
matography based method. In addition, mass results sup-
ported the sertralineelactose condensation product formation
as a complementarymethod. There is some safety information
in the available literature about the Maillard reaction conden-
sation products, which may be genotoxic, carcinogenic, or
cytotoxic [33,36e38], and it would be valuable to collect toxi-
cological data of the products in future cell based studies.Conflicts of interest
The authors have no conflicts of interest.
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